Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
HTX Releases 2025 Recap and 2026 Outlook Report: Trading Volume Steadily Grows and Longtermism Defines the Next Expansion Cycle
-
Kaldalón hf.: Announcement from the Nomination Committee
-
BTCC Exchange Unveils 2026 New Year Trading Festival with Landmark $10 Million Prize Pool
-
KunlunMeta Partners with AMD to Shine at CES
-
BEST FORTUNE. WORLD PARTY. Hong Kong Invites the World to Ring in the Year of the Horse with a Spectacular Cathay International Chinese New Year Night Parade and Citywide Celebrations
-
MEXC Foundation Launches School Supplies Program in Agusan del Sur
-
MEXC Launches Referral Ambassador Program Offering Up to 40% Commissions and Gold Bar Rewards
-
Sanuwave Health Announces Preliminary Q4 2025 Revenue of $13.3–$13.4 Million, Up 29–30% Year-over-Year; Achieves Record Quarterly and Full-Year Revenue
-
Pawn Expert Josh Stern of Fort Lauderdale, FL Explains How to Navigate Lowball Pawn Offers for HelloNation
-
Insurance Expert Michelle Hall of Allegheny County Outlines Common Life Insurance Mistakes for HelloNation
-
Dogecoin Cash, Inc. Becomes Among the First U.S. Public Companies to Complete a FINRA‑Notified Blockchain‑Linked Security Distribution
-
Form 8.5 (EPT/RI)-NCC Group plc
-
Pundi AI Collaborates with OptimAI Network on Agentic AI Development
-
Pundi AI Collaborates with OptimAI Network on Agentic AI Development
-
Prosafe SE: Safe Caledonia contract further extended at Captain
-
Now Available: 1G Live Resin THCA Disposable By The Hemp Doctor
-
Nasdaq Copenhagen A/S godkender afnotering af NTR Holding A/S’ B-aktier
-
VeydooMax V5 Redefines Smart Riding with AI Intelligence and Industrial-Grade Design — Now Debuting in North America at AIMExpo Anaheim
-
At the Yacht Club de Monaco a year of transition and innovation begins
-
MEXC Launches PlusMore (PLUS) Launchpool and Airdrop+ with 18,000 PLUS Rewards
-
O3R-5671 Pharmacokinetic and Pharmacodynamic Data to be Presented at ECCO and Dosing in Final Cohort in First-in-human study initiated
-
HKC Corporation Draws Strong Media Attention at CES 2026
-
Radiant Ridge Energy Announces Strategic Partnership for 40MW Northern Alberta Natural Gas Power Development
-
Crédit Agricole Assurances has priced €750m of Tier 2 subordinated notes at a fixed rate of 4.125% per annum and has set the Maximum Acceptance Amount and the 4.75% Tier 2 Notes Maximum Acceptance
-
Allegro to start production of osteoarthritis hydrogel as it prepares for clinical trials
-
Bekaert - Update on the Share Buyback Program and Liquidity Agreement
-
Pulsar Helium Reports Additional High-Pressure Gas Encounter at Jetstream #5 and Outlines Upcoming Testing Program
-
FORVIA AND SINOPEC CAPITAL PARTNER TO ACCELERATE HYDROGEN GROWTH IN CHINA
-
Zealand Pharma enters agreement with DCAI to use Gefion AI supercomputer to accelerate drug discovery and support Metabolic Frontier 2030 strategy
-
NBPE Announces Transaction in Own Shares
-
Transgene Publishes Phase I Data Supporting TG4050’s Potential in Preventing Head and Neck Cancer Relapse
-
Transaction in Own Shares
-
Preliminary sales-purchase agreement for the sale of properties
-
Same-Day Loans Guaranteed Approval and No Credit Check for Bad Credit Borrowers Introduced by RadCred
-
BlackOpal Attracts $200M to Tokenize Brazilian Credit Card Receivables, Engineering Credit Risk Out of Emerging Market Yield
-
NOVAGOLD Provides Update on Donlin Gold Infrastructure and Energy Supply With Initial Glenfarne Letter of Intent
-
THCA Flower Stats 2026: Exhale Wellness Reports Sales Volume and Buyer Usage Trends Across 10 THCA Flower Strains
-
Sampo plc’s share buybacks 8 January 2026
-
TGS Q4 2025 Operational Update
-
Start of Day Message
-
AS Tallinna Sadam operational volumes for 2025 full year and Q4
-
Valneva to Meet with Investors during the J.P. Morgan Healthcare Conference
-
Tecan reports return to sales growth and strong order entry in the second half of 2025
-
Bitget Deepens Collaboration with Ondo with 98 New US Stocks and ETFs
-
Monte Rosa Therapeutics Announces Pricing of $300 Million Underwritten Public Offering
-
Aktis Oncology Announces Pricing of its Upsized Initial Public Offering
-
Alchera X Advances Industry Leadership with Executive Feature in Leading Technology Publication during CES 2026 in Las Vegas
-
Soren Acquisition Corp. Announces Closing of $253 Million Initial Public Offering
-
Ryoncil® Sales Increase 60% in December Quarter to US$35.1M
-
California Water Service Group Expanding Investment and Operations in Texas
